Biorepository of Biomarkers for Optimization of Microvascular Treatment of Lymphedema

• Conditions: Lymphedema

• Registration Number: NCT04123457
• Lead Sponsor: Mayo Clinic

Brief Summary

Researchers are collecting information, saliva, blood and tissue from subjects with lymphedema to store for future research.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-08-01
• Study First Submitted: 2019-10-09
• Study First Submitted QC: 2019-10-09
• Study First Posted: 2019-10-11
• Status Verified: 2023-09
• Last Update Submitted: 2023-09-12
• Last Update Posted: 2023-09-14
• Primary Completion: 2025-08
• Study Completion: 2025-08

Recruitment & Eligibility

• Status: ENROLLING_BY_INVITATION
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Adult (18+ years of age)
• Ability to provide written consent
• Has been diagnosed with Lymphedema

Exclusion Criteria

• Under the age of 18 years old
• Inability to provide written consent
• Previous lymphovenous bypass or lymph node transfer surgery
• Major changes occur to co-morbid conditions
• Proven ICG or iodine allergy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Biospecimen Acquisition	1 year	Number of biospecimens collected

Trial Locations

Locations (1)

Mayo Clinic in Florida; 🇺🇸 Jacksonville, Florida, United States